Royalty Pharma shareholders approve internalization deal; all director nominees elected

Royalty Pharma plc

Proposal 2 (Membership Interest Purchase Agreement internalization) approved with 440.5M For, 74K Against.
All nine director nominees elected, including Pablo Legorreta, Henry Fernandez, Bonnie Bassler.
Advisory say-on-pay (Proposal 7) passed with 403.2M For, 36.8M Against.
Appointment of Ernst & Young as auditor ratified with 493.5M For, 116K Against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.